A detailed history of Willis Investment Counsel transactions in Medtronic PLC stock. As of the latest transaction made, Willis Investment Counsel holds 350,537 shares of MDT stock, worth $27.6 Million. This represents 2.12% of its overall portfolio holdings.

Number of Shares
350,537
Previous 348,807 0.5%
Holding current value
$27.6 Million
Previous $28.7 Million 6.32%
% of portfolio
2.12%
Previous 2.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$82.84 - $88.09 $143,313 - $152,395
1,730 Added 0.5%
350,537 $30.5 Million
Q4 2023

Jan 11, 2024

SELL
$69.43 - $83.43 $55,752 - $66,994
-803 Reduced 0.23%
348,807 $28.7 Million
Q3 2023

Mar 07, 2024

SELL
$78.22 - $90.4 $2.96 Million - $3.42 Million
-37,845 Reduced 9.77%
349,610 $27.4 Million
Q3 2023

Oct 17, 2023

SELL
$78.22 - $90.4 $2.96 Million - $3.42 Million
-37,845 Reduced 9.77%
349,610 $27.4 Million
Q2 2023

Mar 07, 2024

SELL
$79.47 - $91.38 $7,072 - $8,132
-89 Reduced 0.02%
387,455 $34.1 Million
Q2 2023

Jul 11, 2023

SELL
$79.47 - $91.38 $7,072 - $8,132
-89 Reduced 0.02%
387,455 $34.1 Million
Q1 2023

Mar 07, 2024

BUY
$76.72 - $87.58 $2.97 Million - $3.39 Million
38,737 Added 11.11%
387,544 $31.2 Million
Q1 2023

Apr 18, 2023

BUY
$76.72 - $87.58 $238,138 - $271,848
3,104 Added 0.81%
387,544 $31.2 Million
Q4 2022

Jan 18, 2023

SELL
$76.18 - $87.74 $262,516 - $302,352
-3,446 Reduced 0.89%
384,440 $0
Q3 2022

Oct 12, 2022

BUY
$80.75 - $95.31 $31.3 Million - $37 Million
387,886 New
387,886 $31.3 Million
Q2 2022

Aug 08, 2022

BUY
$87.4 - $113.09 $36.9 Million - $47.7 Million
422,168 New
422,168 $37.9 Million
Q1 2022

May 16, 2022

BUY
$100.58 - $112.38 $580,748 - $648,882
5,774 Added 1.38%
424,795 $47.1 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $2.48 Million - $3.18 Million
24,910 Added 6.32%
419,021 $43.3 Million
Q3 2021

Nov 17, 2021

BUY
$122.75 - $135.17 $3.27 Million - $3.6 Million
26,624 Added 7.24%
394,111 $49.4 Million
Q2 2021

Aug 13, 2021

BUY
$118.19 - $131.5 $2.29 Million - $2.55 Million
19,391 Added 5.57%
367,487 $45.6 Million
Q1 2021

May 17, 2021

SELL
$111.18 - $119.74 $116,183 - $125,128
-1,045 Reduced 0.3%
348,096 $41.1 Million
Q4 2020

Feb 11, 2021

SELL
$100.57 - $117.14 $3.3 Million - $3.84 Million
-32,803 Reduced 8.59%
349,141 $40.9 Million
Q3 2020

Nov 12, 2020

BUY
$90.13 - $108.78 $1.87 Million - $2.25 Million
20,696 Added 5.73%
381,944 $39.7 Million
Q2 2020

Aug 14, 2020

SELL
$84.11 - $103.33 $192,948 - $237,039
-2,294 Reduced 0.63%
361,248 $33.1 Million
Q1 2020

May 13, 2020

BUY
$72.92 - $121.3 $3.89 Million - $6.47 Million
53,377 Added 17.21%
363,542 $32.8 Million
Q4 2019

Feb 13, 2020

BUY
$104.49 - $114.54 $23,719 - $26,000
227 Added 0.07%
310,165 $35.2 Million
Q3 2019

Nov 15, 2019

BUY
$98.02 - $111.18 $2.17 Million - $2.46 Million
22,126 Added 7.69%
309,938 $33.7 Million
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $24.1 Million - $28.5 Million
-286,700 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$82.45 - $93.79 $1.32 Million - $1.5 Million
15,974 Added 5.9%
286,700 $23.8 Million
Q4 2018

Feb 14, 2019

SELL
$85.8 - $99.49 $168,511 - $195,398
-1,964 Reduced 0.72%
270,726 $24.6 Million
Q3 2018

Nov 15, 2018

BUY
$85.91 - $99.17 $6.97 Million - $8.05 Million
81,151 Added 42.37%
272,690 $26.8 Million
Q2 2018

Aug 14, 2018

BUY
$77.48 - $87.83 $1.5 Million - $1.69 Million
19,296 Added 11.2%
191,539 $16.4 Million
Q1 2018

May 11, 2018

BUY
$76.55 - $87.26 $5.72 Million - $6.52 Million
74,710 Added 76.6%
172,243 $13.8 Million
Q4 2017

Feb 14, 2018

SELL
$76.93 - $83.5 $3,769 - $4,091
-49 Reduced 0.05%
97,533 $7.88 Million
Q3 2017

Nov 13, 2017

BUY
$77.71 - $84.6 $7.58 Million - $8.26 Million
97,582
97,582 $7.59 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $105B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Willis Investment Counsel Portfolio

Follow Willis Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Willis Investment Counsel with notifications on news.